TXMD vs. CORT

Last updated Apr 1, 2026

Compare and contrast key facts about TherapeuticsMD, Inc. (TXMD) and Corcept Therapeutics Incorporated (CORT).

Performance

TXMD vs. CORT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in TherapeuticsMD, Inc. (TXMD) and Corcept Therapeutics Incorporated (CORT). The values are adjusted to include any dividend payments, if applicable.

TXMD vs. CORT - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019	2018	2017
TXMD TherapeuticsMD, Inc.	23.93%	89.53%	-61.78%	-59.75%	-68.55%	-70.62%	-50.00%	-36.48%	-36.92%	4.68%
CORT Corcept Therapeutics Incorporated	15.83%	-30.94%	55.14%	59.92%	2.58%	-24.31%	116.20%	-9.43%	-26.02%	148.76%

Fundamentals

EPS TXMD : $0.03 CORT : $0.88
PE Ratio TXMD : 77.42 CORT : 45.97
PEG Ratio TXMD : 0.09 CORT : 22.90
PS Ratio TXMD : 8.36 CORT : 6.52
Total Revenue (TTM) TXMD : $2.80M CORT : $741.17M
Gross Profit (TTM) TXMD : $2.80M CORT : $727.78M
EBITDA (TTM) TXMD : -$974.00K CORT : $72.46M

Returns By Period

In the year-to-date period, TXMD achieves a 23.93% return, which is significantly higher than CORT's 15.83% return. Over the past 10 years, TXMD has underperformed CORT with an annualized return of -39.94%, while CORT has yielded a comparatively higher 23.92% annualized return.

TXMD

• 1D: 1.51%
• 1M: -10.62%
• YTD: 23.93%
• 6M: 87.91%
• 1Y: 118.38%
• 3Y*: -18.63%
• 5Y*: -50.72%
• 10Y*: -39.94%

CORT

• 1D: 5.75%
• 1M: 12.91%
• YTD: 15.83%
• 6M: -51.50%
• 1Y: -64.71%
• 3Y*: 23.00%
• 5Y*: 10.53%
• 10Y*: 23.92%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

TXMD vs. CORT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

TXMD

TXMD Risk / Return Rank: 83
TXMD Sharpe Ratio Rank: 84
TXMD Sortino Ratio Rank: 81
TXMD Omega Ratio Rank: 83
TXMD Calmar Ratio Rank: 87
TXMD Martin Ratio Rank: 78

CORT

CORT Risk / Return Rank: 18
CORT Sharpe Ratio Rank: 8
CORT Sortino Ratio Rank: 12
CORT Omega Ratio Rank: 7
CORT Calmar Ratio Rank: 31
CORT Martin Ratio Rank: 33

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

TXMD vs. CORT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for TherapeuticsMD, Inc. (TXMD) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	TXMD	CORT	Difference
Sharpe ratio Return per unit of total volatility	1.48	-0.82	+2.31
Sortino ratio Return per unit of downside risk	2.19	-0.96	+3.15
Omega ratio Gain probability vs. loss probability	1.32	0.82	+0.49
Calmar ratio Return relative to maximum drawdown	3.35	-0.36	+3.71
Martin ratio Return relative to average drawdown	5.34	-0.58	+5.93
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

TXMD vs. CORT - Sharpe Ratio Comparison

The current TXMD Sharpe Ratio is 1.48, which is higher than the CORT Sharpe Ratio of -0.82. The chart below compares the historical Sharpe Ratios of TXMD and CORT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	TXMD	CORT	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	1.48	-0.82	+2.31
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	-0.27	0.14	-0.41
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	-0.27	0.36	-0.63
Sharpe Ratio (All Time) Calculated using the full available price history	-0.00	0.07	-0.08

Correlation

The correlation between TXMD and CORT is 0.15, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

TXMD vs. CORT - Dividend Comparison

Neither TXMD nor CORT has paid dividends to shareholders.

Tickers have no history of dividend payments

Drawdowns

TXMD vs. CORT - Drawdown Comparison

The maximum TXMD drawdown since its inception was -99.89%, which is greater than CORT's maximum drawdown of -94.28%. Use the drawdown chart below to compare losses from any high point for TXMD and CORT.

Drawdown Indicators

	TXMD	CORT	Difference
Max Drawdown Largest peak-to-trough decline	-99.89%	-94.28%	-5.61%
Max Drawdown (1Y) Largest decline over 1 year	-31.58%	-65.03%	+33.45%
Max Drawdown (5Y) Largest decline over 5 years	-98.96%	-71.85%	-27.11%
Max Drawdown (10Y) Largest decline over 10 years	-99.84%	-71.85%	-27.99%
Current Drawdown Current decline from peak	-99.63%	-64.71%	-34.92%
Average Drawdown Average peak-to-trough decline	-60.89%	-53.45%	-7.44%
Ulcer Index Depth and duration of drawdowns from previous peaks	19.78%	45.10%	-25.32%

Volatility

TXMD vs. CORT - Volatility Comparison

The current volatility for TherapeuticsMD, Inc. (TXMD) is 11.85%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 21.99%. This indicates that TXMD experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	TXMD	CORT	Difference
Volatility (1M) Calculated over the trailing 1-month period	11.85%	21.99%	-10.14%
Volatility (6M) Calculated over the trailing 6-month period	65.18%	85.27%	-20.09%
Volatility (1Y) Calculated over the trailing 1-year period	80.45%	134.82%	-54.37%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	189.53%	73.97%	+115.56%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	145.75%	67.09%	+78.66%

Financials